AAM Report: Generics and Biosimilars Saved $496 Billion in 2025

Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzGeneric and biosimilar drugs jointly created $496 billion in savings in 2025 for the U.S. healthcare system and for patients, according to a new report released by the Association for Accessible Medicines and the Biosimilars Council. Savings over the last decade were $3.5 trillion.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure im